Recently, in the study of a rat model of disuse osteoporosis, irisin treatment increases the bone formation rate of unloading hindlimbs and reduce the expression of pro-inflammatory factors such as tumor necrosis factor (TNF)-α and Interleukin (IL)-17 (Metzger et al., 2020). The gene discussed is FNDC5; the disease is osteoporosis.